Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 5Terminated 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Depression 3Breast Neoplasms 3Brain Neoplasms 3Anxiety Disorders 3Pain, Postoperative 2Urinary Bladder Neoplasms 1Stroke 1Prostatic Neoplasms 1Pain 1Ovarian Neoplasms 1Meningioma 1Erectile Dysfunction 1Emergence Delirium 1Delirium 1Carcinoma, Renal Cell 1Agnosia 1Advanced Ovarian Cancer 1

Interventions

Androgen Antagonists 9darolutamide 6Magnetic Resonance Spectroscopy 6enzalutamide 5apalutamide 5Docetaxel 5Specimen Handling 4Radiotherapy 4Abiraterone Acetate 4Prednisone 3Electroacupuncture 3Brachytherapy 3pembrolizumab 2Standard of Care 2Resistance Training 2Radiosurgery 2Radiation 2Pluvicto 2Interviews as Topic 2Gonadotropin-Releasing Hormone 2Glutamate Carboxypeptidase II 2Bone Density 2Absorptiometry, Photon 2testosterone 17 beta-cypionate 1relugolix 1perflutren 1olaparib 1luprolide acetate gel depot 1fluciclovine F-18 1fezolinetant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Prostatic Neoplasms × Saline Solution × Clear all
NCT07048314 2026-03-19

Stem Cells for Erectile Dysfunction Post RALP

The Methodist Hospital Research Institute

Phase 1/2 Not yet recruiting
40 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡